2019 Annual Meeting

The Limited Sample-Doing More With Less on Aspirates, Biopsies and Intraoperative Consultations

Wednesday, March 20, 2019

Click here for the online program

Physicians can earn a maximum of 6.5 AMA PRA Category 1 Credits
Physicians can earn a maximum of 6 SAM Credit Hours

Course Description

Dermatopathology is a relatively specialized area of pathology requiring additional training; however, skin specimens are commonly encountered in the general surgical pathology practice, frequently constituting a large proportion of the total number of biopsies signed by general surgical pathologists. Accurate diagnosis of these cases entails knowledge of the vast array of potential diagnoses as well as competence in recognizing the histologic clues, which are often subtle, and in integrating the clinical findings. For the practicing pathologist lacking subspecialized training in dermatopathology, diagnosing these specimens may present a daunting task, especially for the less common diseases. In addition, in our age of precision medicine, the information one needs to include in the pathology report often involves ancillary molecular testing. Molecular discoveries with applications in diagnosis, prognosis and management are reported regularly within the literature, and yet, the typical practicing pathologist cannot easily distill this information to that which will meaningfully aid in diagnosis and/ or impact patient care. To this end, the aim of this course is to present the audience with relatively common dermatopathologic lesions and a focus on those entities that create challenges in diagnosis and / or have significant clinical implications. The course will provide a practical approach to common issues encountered in dermatopathology. The audience will be presented with the salient features of each entity, a choice of relevant ancillary tests and tips to avoid misdiagnosis. The course is intended for general surgical pathologists, junior dermatopathologists and pathology residents and fellows.

 

Aleodor (Doru) Andea

Aleodor (Doru) Andea, M.D., MBA
University of Michigan

Course Co-Director

Dr. Andea is a Professor of Pathology and Dermatology and Director of the Dermatopathology Fellowship at the University of Michigan in Ann Arbor, MI. Dr. Andea's areas of expertise are Dermatopathology and Molecular Pathology. Dr. Andea received his M.D. from “Victor Babes” University of Medicine, Timisoara, Romania and completed an Anatomic and Clinical Pathology Residency at Wayne State University in Detroit, Michigan. This was followed by fellowships in Dermatopathology at Medical University of South Carolina, Charleston, SC and Oncologic Pathology and Molecular Pathology at Memorial Sloan-Kettering Cancer Center, New York, NY. After completing his training, Dr. Andea joined the faculty of the Department of Pathology at the University of Alabama at Birmingham (UAB) where he served as Director of the Dermatopathology Fellowship program, Medical Director of the In-situ Hybridization Laboratory and as Dermatopathology Section Head. In 2009 he received the “Leonard H. Robinson” Award for Excellence in Resident Education in Anatomic Pathology. At UAB Dr. Andea developed a research interest in the molecular biology of melanocytic neoplasms and precision molecular diagnostic tests for histologically ambiguous melanocytic tumors. While at UAB, Dr. Andea earned a Master of Business Administration degree from UAB School of Business.

At the University of Michigan, Dr. Andea has established and is leading the Molecular Dermatopathology Research Laboratory which functions as a dermatopathology core facility for skin cancer research and the Dermatopathology Molecular Diagnostics Laboratory providing clinical testing for melanocytic tumors. Dr. Andea has a particular interest in developing and improving ancillary molecular tests to help classify and predict prognosis in histologically ambiguous melanocytic tumors.

Victor G. Prieto

Victor G. Prieto, M.D., Ph.D.
MD Anderson Cancer Center

Course Co-Director

Dr. Prieto is a tenured Professor of Pathology and Dermatology at the University of Texas MD Anderson Cancer Center (MDACC), in Houston, TX. He received his M.D. and Ph.D. (Cellular Biology) degrees from the University of Alicante and University of Barcelona, respectively, both in Spain. After coming to the United States, he completed a residency in Pathology and a fellowship in Dermatopathology at Cornell University in NY City under Dr. Scott McNutt and a fellowship in Oncologic Pathology (Surgical Pathology) at Memorial Sloan Kettering Cancer Center under Dr. Juan Rosai. He then joined Duke University, Durham, NC as an assistant professor. After 3 years, in 1999, he became the section chief of Dermatopathology at MDACC, where he remained until 2016. He became the chair of the Department of Pathology in 2015.

Dr. Prieto’s interests are primarily in melanocytic and other neoplastic diseases in the skin, particularly in the use of immunohistochemistry for the diagnosis and prognostic evaluation of such diseases.

Dr. Prieto has been strongly committed to academic medicine and is or has been either editor or member of several of Pathology and Dermatopathology scientific journals. He has also participated in the administrative work of the ASDP society in both the Executive Committee and the Peer-Review and Mentorship Awards Committees. He is the Secretary-Treasurer of the International Society of Dermatopathology. He is currently the co-director of the Long Course of the USCAP Annual Meeting.

Target Audience

  • Practicing academic pathologists
  • Practicing community pathologists
  • Pathologists-in-Training

Course Objectives

  • Recognize a variety of dermatopathology cases that are prone to be misdiagnosed
  • Identify histological features that are useful in preventing pitfalls in diagnosis
  • Determine appropriate ancillary studies that help arrive at the correct diagnosis

 

Schedule

Start Time Topic/Speaker
8:00 AM Welcome/Introduction of Morning Speakers
Victor G. Prieto, M.D., Ph.D. (Co-Director) MD Anderson Cancer Center, Houston, TX
8:05 AM New Notions of Melanocytic Nevi
Iwei Yeh, M.D., Ph.D., University of California San Francisco, San Francisco CA
8:30 AM See Something, Say Something? What is Important (And What Isn’t) in Reporting Melanoma and Its Variants
Richard Scolyer MBBS, M.D., BMedSi, Royal Prince Alfred Hospital, Camperdown, Australia
9:00 AM Through The Glass Slide and What You Find There: Making Sense of Molecular Tests for Melanoma Diagnosis
Aleodor (Doru) Andea, M.D., M.B.A., University of Michigan, Ann Arbor, MI
9:25 AM Questions
9:30 AM Break
10:30 AM Don’t Break a Sweat: Avoiding Pitfalls in the Diagnosis of Sweat Gland Tumors
Thomas Brenn, M.D., Ph.D., University of Calgary, Calgary, Canada
11:00 AM Solving The Conundrum: A Practical Approach to the Diagnosis of Adnexal Neoplasms with Follicular and Sebaceous Differentiation
Doina Ivan, M.D.
11:30 AM Danger Can Be Only Skin Deep: Aggressive Epidermal Carcinomas
Michael Tetzlaff, M.D., Ph.D., MD Anderson Cancer Center, Houston, TX
11:55 AM Questions
12:00 PM Lunch
1:00 PM Introduction of Afternoon Speakers
Aleodor (Doru) Andea, M.D., M.B.A. (Co-Director), University of Michigan, Ann Arbor, MI
1:05 PM Cutaneous Soft Tissue Tumors: How Do We Make Sense of Fibrous and "Fibrohistiocytic" Tumors with Confusing Names and Similar Appearances?
Jason L. Hornick, M.D., Ph.D., Brigham and Women's Hospital, Boston, MA
1:35 PM Cutaneous Soft Tissue Tumors: Diagnostically Disorienting Epithelioid Tumors That Are Not Epithelial, and Other Perplexing Mesenchymal Lesions
Rajiv Patel, M.D., University of Michigan, Ann Arbor, MI
2:00 PM Questions
2:05 PM Challenges in the Diagnosis of T-Cell Lymphoid Proliferations of the Skin: Putting All The Pieces Together
Carlos Torres-Cabala, MD, MD Anderson Cancer Center, Houston, TX
2:30 PM Break
3:30 PM Navigating the Cutaneous B-cell lymphomas – Avoiding the Rocky Shoals
Elaine S Jaffe, M.D., National Cancer Institute, Bethesda, MD
4:00 PM Common and Critical Inflammatory Dermatoses Every Pathologist Should Know
Steven D. Billings, M.D., Cleveland Clinic, Cleveland, OH
4:30 PM Emerging Infections in Dermatopathology
Francisco Bravo, M.D., Universidad Peruana Cayetano Heredia, Lima, Peru
4:55 PM How to Avoid the Common Traps/Pitfalls in Dermatopathology
Victor G. Prieto, M.D., Ph.D., MD Anderson Cancer Center, Houston, TX
5:20 PM Questions and Closing Remarks

 

Continuing Medical Education and Continuing Certification

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Continuing Certification (CC). Learners must take and pass the post-test in order to claim SAMs credit.

Physicians can earn a maximum of 6 SAM credit hours.

Meetings

view more